Home › Funds › GUGGENHEIM CAPITAL LLC › GILD
GUGGENHEIM CAPITAL LLC position in GILD
GILEAD SCIENCES INC · Health Care
GUGGENHEIM CAPITAL LLC reported holding 398,367 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$59.4M, representing 0.39% of its reported portfolio and ranking #46 among its reported holdings. GUGGENHEIM CAPITAL LLC has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How GUGGENHEIM CAPITAL LLC's GILD position evolved
GUGGENHEIM CAPITAL LLC first disclosed a stake in GILD in Q3 2023 at 766,780 shares (US$57.5M). The position peaked in Q4 2025 at 517,789 shares, worth US$63.6M. Across 13 filings, GUGGENHEIM CAPITAL LLC increased the stake 2 time(s), trimmed it 9 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 398,367 shares valued at US$59.4M — a reduction of -18,290 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 766.78K | $57.46M | New |
| Q4 2023 | 760.40K | $61.60M | Reduce |
| Q1 2024 | 695.90K | $50.97M | Reduce |
| Q2 2024 | 777.91K | $53.37M | Add |
| Q3 2024 | 681.49K | $57.14M | Reduce |
| Q4 2024 | 647.25K | $59.79M | Reduce |
| Q1 2025 | 531.22K | $59.52M | Reduce |
| Q2 2025 | 560.94K | $62.19M | Add |
| Q3 2025 | 528.86K | $58.70M | Reduce |
| Q4 2025 | 517.79K | $63.55M | Reduce |
| Q1 2026 | 416.45K | $58.04M | Reduce |
| Q2 2026 | 416.66K | $52.64M | Hold |
| Q3 2026 | 398.37K | $59.38M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GILD and 13F data
GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include BlackRock Inc (US$18.67B), Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GILD
- BlackRock Inc 125.25M sh · $18.67B · Q3 2026
- Fidelity Management & Research (FMR) 58.27M sh · $8.68B · Q3 2026
- Invesco Ltd 38.66M sh · $5.76B · Q3 2026
- Capital World Investors 35.93M sh · $5.36B · Q3 2026
- Capital World Investors 40.99M sh · $5.18B · Q2 2026
- PRICE T ROWE ASSOCIATES INC /MD/ 30.00M sh · $3.79B · Q2 2026
- Capital Research Global Investors 23.98M sh · $3.57B · Q3 2026
- DODGE & COX 21.80M sh · $3.25B · Q3 2026
- Dodge & Cox 23.68M sh · $2.99B · Q2 2026
- MFS Investment Management 11.46M sh · $1.77B · Q3 2026
- Amundi US 11.26M sh · $1.68B · Q3 2026
- Legal & General Investment Management America 10.40M sh · $1.55B · Q3 2026
More on GUGGENHEIM CAPITAL LLC
FAQ
How long has GUGGENHEIM CAPITAL LLC held GILD?
GUGGENHEIM CAPITAL LLC has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is GUGGENHEIM CAPITAL LLC's current position in GILD?
As of Q3 2026, GUGGENHEIM CAPITAL LLC holds 398.37K shares of GILD (GILEAD SCIENCES INC), valued at $59.38M, representing 0.39% of its reported portfolio and ranking #46.
Has GUGGENHEIM CAPITAL LLC been buying or selling GILD?
In the latest 13F filing (Q3 2026), GUGGENHEIM CAPITAL LLC reduced its position in GILD. The position peaked in Q4 2025 at 517.79K shares.
Which other funds hold GILD?
Other major institutional holders of GILD include BlackRock Inc, Fidelity Management & Research (FMR), Invesco Ltd, among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.